Sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia

Cognitive and Behavioral Practice

Volumn 12, Issue 1, 2005, Pages 17-29

  Morissette, Sandra Baker ^a,b,c,e   Spiegel, David A ^a   Heinrichs, Nina ^a,d  

^a BOSTON UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^e VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BRONCHODILATING AGENT; SEDATIVE AGENT;

AGORAPHOBIA; ASTHMA; BEHAVIOR THERAPY; COGNITION; COGNITIVE THERAPY; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; HUMAN; MENTAL DISEASE; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPIST; RATING SCALE; REVIEW; SENSATION FOCUSED INTENSIVE TREATMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 32444441152     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(05)80036-7     Document Type: Article

References (45)

1. American Psychiatric Association. (1994). Diagnostic, and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Baker, S. L., Patterson, M. D., & Barlow, D. H. (2002). Panic disorder and agoraphobia. In M. M. Antony & D. H. Barlow (Eds.), Handbook of assessment and treatment planning far psychological disorders. New York: The Guilford Press.
3. Baker, S. L., Spiegel, D. A., & Barlow, D. H. (1999, August). Two-week cognitive behavioral treatment of severe agoraphobia: A case study. Poster presented at the annual meeting of the American Psychological Association, Boston, MA.
4. Baker-Morissette, S. L., Gulliver, S. B., Wiegel, M., & Barlow, D. H. (2004). Prevalence of smoking in anxiety disorders uncomplicated by comorbid alcohol or substance abuse. Journal of Psychopathology and Behavioral Assessment, 26, 107-112.
5. Barlow, D. H., & Craske, M. G. (2000). Mastery of your anxiety and panic (MAP-III): Client workbook (3rd ed.). San Antonio, TX: Psychological Corporation.
6. Barlow, D.H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association, 283, 2529-2536.
7. Başoǧlu, M., Marks, I. M., Kilic, C., Brewin, C. R., & Swinson, R. P. (1994). Alprazolam and exposure for panic disorder with agoraphobia attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652-659.
8. Brown, T. A., & Barlow, D. H. (1995). Long-term outcome of cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. Journal of Consulting and Clinical Psychology, 63, 754-765.
9. Brown, T. A., DiNardo, P. A., & Barlow, D. H. (1994). Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV). San Antonio, TX: Psychological Corporation/Graywind Publications.
10. Bruce, T. J., Spiegel, D. A., & Hegel, M. T. (1999). Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies. Journal of Consulting and Clinical Psychology, 67, 151-156.
11. Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994). A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. The British Journal of Psychiatry, 164, 759-769.
12. Craske, M. G., Barlow, D. H., & Meadows, E. A. (2000). Mastery of your anxiety and panic. (MAP-III): Therapist guide for anxiety, panic, and agoraphobia (3rd ed.). San Antonio, TX: Psychological Corporation.
13. Craske, M. G., & Rowe, M. K. (1997). Nocturnal panic. Clinical Psychology: Science and Practice, 4, 153-174.
14. Craske, M. G., Rowe, M., Lewin, M., & Noriega-Dimitri, R. (1997). Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia. British Journal of Clinical Psychology, 36, 85-99.
15. Cottreaux, J., Note, I. D., Cungi, C., Legeron, P., Heim, F., Chneiweiss, L., Bernard, G., & Bouvard, M. (1995). A controlled study of cognitive behavior therapy with buspirone or placebo in panic disorder with agoraphobia. The British Journal of Psychiatry, 167, 635-641.
16. DiNardo, P. A., Brown, T. A., & Barlow, D. H. (1994). Anxiety Disorders Interview Schedule far DSM-IV: Lifetime. Version (ADIS-IV-L). San Antonio, TX: Psychological Corporation/Graywind Publications.
17. Ehlers, A., Fiegenbaum, W., Florin, I., & Margraf, J. (1995, July). Efficacy of exposure in vivo in panic disorder with agoraphobia in a clinical setting. Paper presented at the World Congress of Behavioural and Cognitive Therapies, Copenhagen, Denmark.
18. Falsetti, S. A., & Resnick, H. S. (2000). Cognitive behavioral treatments for PTSD with comorbid panic attacks. Journal of Contemporary Psychotherapy, 30, 163-179.
19. Falsetti, S. A., Resnick, H. S., Davis, J., & Gallagher, N. G. (2001). Treatment of posttraumatic stress disorder with comorbid panic attacks: Combining cognitive processing therapy with panic control treatment techniques. Group Dynamics, 5, 252-260.
20. Fava, G. A., Zielenzny, M., Savron, G., & Grandi, S. (1995). Long-term effects of behavioural treatment for panic disorder and agoraphobia. British Journal of Psychiatry, 166, 87-92.
21. Feldman, J. M., Giardino, N. D., & Lehrer, P. M. (2000). Asthma and panic disorder. In D. I. Mostofsky & D. H. Barlow (Eds.), The management of stress and anxiety in medical disorders. Boston: Allyn & Bacon.
22. Fiegenbaum, W. (1988). Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In I. Hand & H. Wittchen (Eds.), Panic and phobias: Treatments and variables affecting course, and outcome (pp. 83-88). Berlin: Springer-Verlag.
23. Fiegenbaum, W., & Tuschen, B. (1996). Reizkonfrontation [Cue exposure]. In J. Margraf (Ed.), Lehrbuch der Verhaltenstherapie (Kap. 21) [Handbook of Behavior Therapy (Ch. 21)]. Berlin: Springer.
24. Guarnaccia, P. J., Canino, G., Rubio-Stipec, M., & Bravo, M. (1993). The prevalence of ataques de nervios in the Puerto Rico Disaster Study. Journal of Nervous and Mental Disease, 181, 157-165.
25. Guarnaccia, P. J., Rubio-Stipec, M., & Canino, G. J. (1989). Ataques de nervios in the Puerto Rican Diagnostic Interview Schedule: The impact of cultural categories on psychiatric epidemiology. Culture, Medicine, and Psychiatry, 13, 275-295.
26. Heinrichs, N., Hahlweg, K., & Fiegenbaum, W. (2002). Pretreatment patient factors predicting attrition and effectiveness of intensive exposure therapy for panic disorder with agoraphobia in the field. Unpublished manuscript.
27. Heinrichs, N., Spiegel, D. A., & Hofmann, S. G. (2002). Panic disorder with agoraphobia. In F. W. Bond & W. Dryden (Eds.), Handbook of brief cognitive behaviour therapy (pp. 55-76). Chichester: John Wiley & Sons.
28. Hinton, D., Ba, P., Peou, S., & Um, K. (2000). Panic disorder among Cambodian refugees attending a psychiatric clinic: Prevalence and subtypes. General Hospital Psychiatry, 22, 437-444.
29. Houck, P. R., Spiegel, D. A., Shear, K., & Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. Depression and Anxiety, 14, 183-185.
30. Keller, M. B., Yonkers, K. A., Warshaw, M. G., Pratt, L. A., Golan, J., Mathews, A. O., White, K., Swots, A., Reich, J., & Lavori, P. (1994). Remission and relapse in subjects with panic disorder and agoraphobia: A prospective short interval naturalistic follow-up. Journal of Nervous and Mental Disease, 182, 290-296.
31. Liebowitz, M. R., Salman, E., Jusino, C. M., Garfinkel, R., Street, L., Cardenas, D. L., Silvestre, J., Fyer, A. J., Carrasco, J. L., Davies, S. Guarnaccia, P., & Klein, D. F. (1994). Attiques de nervios und panic disorder. American Journal of Psychiatry, 151, 871-875.
32. Miller, W. R., & Rollnick, S. (1991). Motivational Interviewing: Preparing people to change addictive behavior. New York: The Guilford Press.
33. Otto, M. W., Pollack, M. H., & Sabatino, S. A. (1996). Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment. Behavior Therapy, 27, 473-482.
34. Otto, M. W., Pollack, M. H., Sachs, G. S., O'Neil, C. A., & Rosenbaum, J. F. (1992). Alcohol dependence in panic disorder patients. Journal of Psychiatric Research, 26, 29-38.
35. Pincus, D., Spiegel, D., Barlow, D. H., Mattis, S. M., Cohen, L. S., & Micco, J. (2001, November). Intensive 8-day treatment of panic disorder and agoraphobia in adolescents. Paper presented at the meeting of the Association for Advancement of Behavior Therapy, Philadelphia, PA.
36. Rapee, R. M., Craske, M. G., & Barlow, D. H. (1995). Assessment instrument for panic disorder that includes fear of sensation-producing activities: The Albany Panic and Phobia Questionnaire. Anxiety, 1, 114-122.
37. Reiss, S., Peterson, R. A., Gursky, M., & McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency, and prediction of fearfulness. Behaviour Research and Therapy, 24, 1-8.
38. Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997). Multicenter collaborative panic disorder scale. American Journal of Psychiatry, 154, 1571-1575.
39. Spiegel, D. A. (2001). Heating anxiety and fear: Patient handbook. Unpublished manuscript.
40. Spiegel, D. A., & Baker-Morissette, S. L. (2003). Heating anxiety and fear: Therapist guide. Unpublished manuscript.
41. Spiegel, D. A., & Barlow, D. H. (2000, November). 8-Day treatment of panic disorder with moderate to severe agoraphobia: Preliminary outcome data. Poster presented at the Annual Meeting of the Association for Advancement of Behavior Therapy, New Orleans, LA.
42. Spiegel, D. A., & Bruce, T. J. (1997). Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: Conclusions from combined treatment trials. American Journal of Psychiatry, 154, 773-781.
43. Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry, 151, 876-881.
44. Tuschen, B., & Fiegenbaum, W. (1997). Techniques of exposure. In W. T. Roth & I. D. Yaloni (Eds.), Treating anxiety disorders (pp. 31-55). San Francisco: Jossey-Bass.
45. White, K. S., & Barlow, D. H. (2002). Panic disorder and agoraphobia. In D. H. Barlow (Ed.), Anxiety and its disorders (pp. 328-379). New York: The Guilford Press.